Kent J M, Papp L A, Martinez J M, Browne S T, Coplan J D, Klein D F, Gorman J M
Biological Studies Unit, New York State Psychiatric Institute, New York, NY 10032, USA.
Am J Psychiatry. 2001 Jan;158(1):58-67. doi: 10.1176/appi.ajp.158.1.58.
The behavioral response to CO(2) inhalation has been used to differentiate panic disorder patients from normal subjects and other clinical populations. This study extended examination of the diagnostic specificity of CO(2)-induced anxiety by testing panic disorder patients and clinical populations with reported low and high sensitivity to CO(2) inhalation (patients with major depression and patients with premenstrual dysphoric disorder, respectively).
The behavioral responses to inhalation of 5% and 7% CO(2), administered by means of a respiratory canopy, were studied in 50 patients with panic disorder, 21 with major depression, and 10 with premenstrual dysphoric disorder and in 34 normal comparison subjects. Occurrence of panic attacks was judged with DSM-IV criteria by a blind rater. Subjects were rated on three behavioral scales at baseline and after each CO(2) inhalation.
Panic disorder patients had a higher rate of CO(2)-induced panic attacks than depressed patients and normal subjects, whose panic rates were not distinguishable. The panic rate for patients with premenstrual dysphoric disorder was similar to that for panic disorder patients and higher than that for normal subjects. Subjects with CO(2)-induced panic attacks had similarly high ratings on the behavioral scales, regardless of diagnosis, including the small number of panicking normal subjects. Seven percent CO(2) was a more robust panicogen than 5%, and response to 7% CO(2 )better distinguished panic disorder patients from normal subjects than response to 5% CO(2).
Patients with panic disorder and patients with premenstrual dysphoric disorder are highly susceptible to CO(2)-induced panic attacks, and depressed patients appear to be insensitive to CO(2) inhalation. The symptoms of CO(2)-induced panic attacks have a similar intensity regardless of the subject's diagnosis.
吸入二氧化碳后的行为反应已被用于区分惊恐障碍患者与正常受试者以及其他临床群体。本研究通过测试惊恐障碍患者以及报告对吸入二氧化碳敏感度低和高的临床群体(分别为重度抑郁症患者和经前烦躁障碍患者),扩展了对二氧化碳诱发焦虑诊断特异性的检验。
采用呼吸面罩给予5%和7%的二氧化碳进行吸入,研究了50例惊恐障碍患者、21例重度抑郁症患者、10例经前烦躁障碍患者以及34名正常对照受试者的行为反应。由一名盲法评定者依据《精神疾病诊断与统计手册》第四版标准判断惊恐发作的发生情况。在基线时以及每次吸入二氧化碳后,对受试者进行三种行为量表的评分。
惊恐障碍患者中二氧化碳诱发惊恐发作的发生率高于抑郁症患者和正常受试者,后两者的惊恐发生率无显著差异。经前烦躁障碍患者的惊恐发生率与惊恐障碍患者相似,且高于正常受试者。无论诊断如何,包括少数出现惊恐发作的正常受试者在内,因二氧化碳诱发惊恐发作的受试者在行为量表上的评分同样较高。7%的二氧化碳比5%的二氧化碳更易诱发惊恐发作,相较于对5%二氧化碳的反应,对7%二氧化碳的反应能更好地区分惊恐障碍患者与正常受试者。
惊恐障碍患者和经前烦躁障碍患者对二氧化碳诱发的惊恐发作高度敏感,而抑郁症患者似乎对吸入二氧化碳不敏感。无论受试者的诊断如何,二氧化碳诱发惊恐发作的症状强度相似。